Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Open-label (Core Phase Plus Extension Phase) With 2 Cohorts Study to Assess the Pharmacokinetics and Safety of Givinostat in DMD Patients Ages From at Least 2 Years to Less Than 6 Years Old

NCT06769633 is registered in ClinicalTrials.gov with Italfarmaco as lead sponsor.

NCT NCT06769633
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06769633 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Open-label (Core Phase Plus Extension Phase) With 2 Cohorts Study to Assess the Pharmacokinetics and Safety of Givinostat in DMD Patients Ages From at Least 2 Years to Less Than 6 Years Old
Lead sponsor
Italfarmaco
Phase
Phase 2
Overall status
Recruiting
Start date
January 2, 2025
Completion date
December 31, 2029
Enrollment
18 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

duchenne muscular dystrophy